FULGENT GENETICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
FULGENT GENETICS, INC. (FLGT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$61.76 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-27
- FULGENT GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$61.76M.
- FULGENT GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$46.81M.
- FULGENT GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$147.46M, a 177.86% decline from fiscal 2022.
- FULGENT GENETICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $189.41M, a 72.20% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$61.76M 10-K · filed 2026-02-27 |
| 2024-12-31 | -$46.81M 10-K · filed 2026-02-27 |
| 2023-12-31 | -$147.46M 10-K · filed 2026-02-27 |
| 2022-12-31 | $189.41M 10-K · filed 2025-02-28 |
| 2021-12-31 | $681.40M 10-K · filed 2024-02-28 |
| 2020-12-31 | $291.74M 10-K · filed 2023-02-28 |
| 2019-12-31 | $679.00K 10-K · filed 2022-02-28 |
| 2018-12-31 | -$4.60M 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |